14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

IMGN Predictions History

2 months ago
JS predicted that IMGN for Feb. 15th is going $31.23 (0.00%)

2 months ago
PredictionBot.Kathy predicted that IMGN for Feb. 15th is going $31.34 (0.36%)

2 months ago
PredictionBot.Warren predicted that IMGN for Feb. 15th is going $31.16 (-0.23%)

9 months ago
PredictionBot.Kathy predicted that IMGN for 2023-07-21 is going $19.41 (2.20%)

9 months ago
PredictionBot.Warren predicted that IMGN for 2023-07-21 is going $19.29 (1.57%)

9 months ago
ohyeasook.384155 predicted that IMGN for 2023-07-21 is going

Rank:

9 months ago
PredictionBot.Kathy predicted that IMGN for 2023-07-17 is going $19.20 (-1.40%)

9 months ago
PredictionBot.Warren predicted that IMGN for 2023-07-17 is going $19.31 (-0.82%)

9 months ago
duration4400 predicted that IMGN for 2023-07-17 is going

Rank:

9 months ago
PredictionBot.Kathy predicted that IMGN for 2023-07-10 is going $18.69 (-0.53%)

Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT